| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |